Gajewski JL - Search Results

1

Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation.

Schiller GJ, Nimer SD, Gajewski JL, Golde DW. Schiller GJ, et al. Among authors: gajewski jl. Bone Marrow Transplant. 1991 Jun;7(6):489-91. Bone Marrow Transplant. 1991. PMID: 1843181

2

Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial.

Nimer SD, Giorgi J, Gajewski JL, Ku N, Schiller GJ, Lee K, Territo M, Ho W, Feig S, Selch M, et al. Nimer SD, et al. Among authors: gajewski jl. Transplantation. 1994 Jan;57(1):82-7. doi: 10.1097/00007890-199401000-00015. Transplantation. 1994. PMID: 8291119 Clinical Trial.

3

Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.

Schiller G, Feig SA, Territo M, Wolin M, Lill M, Belin T, Hunt L, Nimer S, Champlin R, Gajewski J. Schiller G, et al. Br J Haematol. 1994 Sep;88(1):72-8. doi: 10.1111/j.1365-2141.1994.tb04979.x. Br J Haematol. 1994. PMID: 7803259

4

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.

Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. Schiller G, et al. Bone Marrow Transplant. 1994 Jul;14(1):131-6. Bone Marrow Transplant. 1994. PMID: 7951100 Clinical Trial.

5

Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.

Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Schiller GJ, et al. Among authors: gajewski jl. J Clin Oncol. 1992 Jan;10(1):41-6. doi: 10.1200/JCO.1992.10.1.41. J Clin Oncol. 1992. PMID: 1727924

6

Treatment of acute myelogenous leukemia in the elderly.

Champlin RE, Gajewski JL, Golde DW. Champlin RE, et al. Among authors: gajewski jl. Semin Oncol. 1989 Feb;16(1):51-6. Semin Oncol. 1989. PMID: 2645650 Review.

7

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.

Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. Schiller G, et al. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. Br J Haematol. 1992. PMID: 1643014 Clinical Trial.

8

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. Leuk Lymphoma. 1993. PMID: 8220156 Clinical Trial.

9

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.

Schiller G, Lee M, Territo M, Gajewski J, Nimer S. Schiller G, et al. Am J Hematol. 1993 Jul;43(3):195-9. doi: 10.1002/ajh.2830430307. Am J Hematol. 1993. PMID: 8352235 Clinical Trial.

10

Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J. Sahebi F, et al. Bone Marrow Transplant. 1996 May;17(5):685-9. Bone Marrow Transplant. 1996. PMID: 8733682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters